Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Initiative against diabetes amputations launched:

This article was originally published in Clinica

Executive Summary

The diabetes alliance of Boehringer Mannheim and Eli Lilly has launched a footcare initiative aimed at reducing the number of diabetes-related amputations. One in six of the more than 100 million diabetics worldwide suffers from non-healing leg and foot ulcers and 5-10% of diabetic foot ulcers result in amputations. The initiative will develop guidelines covering prevention, patient education, diagnosis, management, pathogenesis and the training of healthcare organisations and professionals.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093278

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel